Metabolic modulation for cardiac protection.
Weinberg
Guy L
GL
Massad
Malek G
MG
D000818:Animals; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000379:methods; D002314:Cardioplegic Solutions / Q000627:therapeutic use*; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006324:Heart Arrest, Induced; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D015227:Lipid Peroxidation; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000378:metabolism* / Q000517:prevention & control*; D009206:Myocardium / Q000378:metabolism*; D010084:Oxidation-Reduction; D010101:Oxygen Consumption; D011183:Postoperative Complications / Q000517:prevention & control; D011188:Potassium / Q000627:therapeutic use; D019289:Pyruvic Acid / Q000627:therapeutic use; D051381:Rats; D012680:Sensitivity and Specificity
D002314:Cardioplegic Solutions; D007328:Insulin; D019289:Pyruvic Acid; D005947:Glucose; D011188:Potassium